Amerisourcebergen (holding ) Stock News

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment.

Here is how AmerisourceBergen (ABC) and Celularity, Inc. (CELU) have performed compared to their sector so far this year.

AmerisourceBergen Corporation with ticker code (ABC) have now 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 180 and 139 and has a mean target at 153.92. Given that the stocks previous close was at 137.86 this now indicates there is a potential upside of 11.6%. The 50 day moving average now sits at 134.8 and the 200 day MA is 123.66. The market cap for the company is $29,681m. Find out more information at: https://www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets=ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $33,138m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.

Drug distributors McKesson, AmerisourceBergen and Cardinal Health are part of the settlement.

The three largest pharmaceutical distributors have approved the $19.5 billion settlement with states and municipalities over expenses of the opioid crisis.

Johnson & Johnson (NYSE: JNJ ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible for the opioid abuse crisis. The other companies are distributors McKesson Corp (NYSE: MCK ), AmerisourceBergen Corp (NYSE: ABC ) and Cardinal Health Inc (NYSE: CAH ). Johnson & Johnson was up 4.97% at $166 Friday afternoon at publication. See Also: Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits Johnson & Johnson Daily Chart Analysis The stock recently bounced off support in a sideways channel and has been pushing higher, now nearing the resistance level of the channel. Support was found near … Full story available on Benzinga.com

Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis Friday, an announcement that clears the way for $26 billion to flow to nearly every state and local government in the U.S. Taken together, the settlements are the largest to date among the many opioid-related cases that have been playing out across the country. They''re expected to provide a significant boost to efforts aimed at reversing the crisis in places that have been devastated by it, including many parts of rural America. Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKesson announced the settlement plan last year, but the deal was contingent on getting participation from a critical mass of state and local governments. Friday was the deadline for the companies to announce whether they felt enough governments had committed to participate in the settlement and relinquish the right to sue. The four companies notified lawyers for the governments in the case that their thresholds were met, meaning money could start flowing to communities by April. "We''re never going to have enough money to immediately cure this problem," said Joe Rice, one of the lead lawyers who represented local governments in the litigation that led to the settlement. "What we''re trying to do is give a lot of small communities a chance to try to change some of their problems." While none of the settlement money will go directly to victims of opioid addiction or their survivors, the vast majority of it is required to be used to deal with the epidemic.

Johnson and Johnson and three other major drug distributors on Friday finalized a historic $26 billion settlement in an opioid lawsuit brought against the companies.The settlement agreement with Johnson and Johnson, AmerisourceBergen, Cardinal…

MADISON, Wis. – Attorney General Kaul announced today the final approval of the $26 billion opioid agreement with the nation’s three major pharmaceutical distributors – Cardinal, McKesson, and AmerisourceBergen – and Johnson & Johnson. Following successful state sign-on and subdivision sign-on periods, the defendants will start releasing funds to a national administrator on April 2, […]

Distributors McKesson Corporation (NYSE: MCK ), AmerisourceBergen Corp (NYSE: ABC ), Cardinal Health Inc (NYSE: CAH ), and Johnson & Johnson (NYSE: JNJ ) have agreed to finalize a proposed $26 billion settlement resolving claims by states and local governments regarding the opioid epidemic. The deal aims to resolve more than 3,000 lawsuits, mainly by state and local governments seeking to hold the companies responsible for … Full story available on Benzinga.com

The three distributors, McKessen, AmerisourceBergen and Cardinal Health, each "independently determined" that enough states and litigating political subdivisions had signed on to advance the agreement to pay out $19.5 billion over 18 years to thousands of plaintiffs, according to a joint press release from the companies.

BET À DAY Drugmaker Johnson & Johnson and three major distributors (McKessen, AmerisourceBergen and Cardinal Health) confirmed on Friday that they will pay $24.5 billion to end more than 3,000 lawsuits by US states and thousands of communities. In a joint statement, the distributors said they had independently determined that there was “sufficient participation from […] The post Opiate crisis: J&J and 3 distributors agree to pay nearly 25 billion dollars first appeared on The Bobr Times .

AmerisourceBergen, Cardinal Health and McKesson said they would proceed with a settlement of the majority of the opioid lawsuits filed by state and local governments in the U.S.

AmerisourceBergen, Cardinal Health and McKesson said they agreed to proceed with a settlement of the majority of the opioid lawsuits filed by state and local governments in the U.S.